Showing results (421-430 of 432) with videos related to

Sort By:
Pageof 44
Trials|August 1, 2021
An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept studyArjune Sen, Mary Akinola, Xin You Tai, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 10, 2019
Recommendations for the Nonpharmacological Treatment of Apathy in Brain DisordersValeria Manera, Sharon Abrahams, Luis Agüera-Ortiz, et al.
Neurology|August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple SclerosisSarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Epilepsia Open|October 14, 2024
Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trialArjune Sen, Sofia Toniolo, Xin You Tai, et al.
Translational Psychiatry|April 8, 2026
The social dimension of apathy: evidence for a distinct domain from 11,243 individuals across health and neurocognitive disordersSijia Zhao, Rong Ye, Qian-Yuan Tang, et al.
JAMA Neurology|March 12, 2019
Association of Piriform Cortex Resection With Surgical Outcomes in Patients With Temporal Lobe EpilepsyMarian Galovic, Irene Baudracco, Evan Wright-Goff, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2026
Early Versus Delayed Anticoagulation in Acute Ischaemic Stroke with Atrial Fibrillation According to Infarct Volume and Location: a Prespecified Subgroup Analysis of the OPTIMAS Randomised Controlled TrialPhilip S Nash, Jonathan Best, James Lyon, et al.
Nature Aging|November 22, 2021
Dissociable effects of APOE-ε4 and β-amyloid pathology on visual working memoryKirsty Lu, Jennifer M Nicholas, Yoni Pertzov, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 5, 2021
Diagnostic criteria for apathy in neurocognitive disordersDavid S Miller, Philippe Robert, Larry Ereshefsky, et al.
Bjpsych Open|November 6, 2025
Characterising negative symptoms in schizophrenia: CHANSS study protocolNoham Wolpe, Clàudia Aymerich, Ying Jin, et al.
Pageof 44